Article
BRAF Testing in Multifocal Papillary Thyroid Carcinoma.
BioMed research international - 1 Jan 2015
Kimbrell Hillary Z, Sholl Andrew B, Ratnayaka Swarnamala, Japa Shanker, Lacey Michelle, Carpio Gandahari, Bhatia Parisha, Kandil Emad
Abstract excerpt
BACKGROUND: BRAF V600E mutation is associated with poor prognosis in patients with papillary thyroid carcinoma (PTC). PTC is often multifocal, and there are no guidelines on how many tumors to test for BRAF mutation in multifocal PTC. METHODS: Fifty-seven separate formalin-fixed and paraffin-embedded PTCs from twenty-seven patients were manually macrodissected and tested for BRAF mutation using a commercial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
